MBX Biosciences, Inc.
Q3 2024 13F Holders
Symbol
MBX
CUSIP
55287L101
Type
Equity
Class
COM
Num filings
45
Total reported value, excl. options
$783 M
Compare 2024 Q3 to
2025 Q1
2024 Q4
Manager
Report Date
Value ($000)
Shares
Option Type